NZ591757A - Modified variant bowman birk protease inhibitors - Google Patents

Modified variant bowman birk protease inhibitors

Info

Publication number
NZ591757A
NZ591757A NZ591757A NZ59175708A NZ591757A NZ 591757 A NZ591757 A NZ 591757A NZ 591757 A NZ591757 A NZ 591757A NZ 59175708 A NZ59175708 A NZ 59175708A NZ 591757 A NZ591757 A NZ 591757A
Authority
NZ
New Zealand
Prior art keywords
modified variant
bbpis
modified
bowman birk
protease inhibitors
Prior art date
Application number
NZ591757A
Inventor
Katherine D Collier
Melodie Estabrook
David A Estell
Neelam S Amin
Bryan Fox
Scott D Power
Brian F Schmidt
Gudrun Vogtentanz
Original Assignee
Danisco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco Us Inc filed Critical Danisco Us Inc
Priority to NZ591757A priority Critical patent/NZ591757A/en
Priority claimed from PCT/US2008/079951 external-priority patent/WO2010044786A1/en
Publication of NZ591757A publication Critical patent/NZ591757A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Disclosed are modified variant Bowman Birk Protease Inhibitor proteins (BBPIs) that comprise peptides that bind target proteins, and that are further modified to have greater protease inhibitory activity and/or be produced at greater yields than the unmodified BBPIs. The invention encompasses polynucleotide constructs and expression vectors containing polynucleotide sequences that encode the modified variant BBPIs, the transformed host cells that express and produce the modified variant BBPIs, the modified variant BBPI proteins, the compositions comprising the modified variant BBPIs, and the methods for making and using the modified variant BBPIs in personal care.
NZ591757A 2008-10-15 2008-10-15 Modified variant bowman birk protease inhibitors NZ591757A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ591757A NZ591757A (en) 2008-10-15 2008-10-15 Modified variant bowman birk protease inhibitors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ591757A NZ591757A (en) 2008-10-15 2008-10-15 Modified variant bowman birk protease inhibitors
PCT/US2008/079951 WO2010044786A1 (en) 2008-10-15 2008-10-15 Modified variant bowman birk protease inhibitors

Publications (1)

Publication Number Publication Date
NZ591757A true NZ591757A (en) 2012-09-28

Family

ID=46883039

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ591757A NZ591757A (en) 2008-10-15 2008-10-15 Modified variant bowman birk protease inhibitors

Country Status (1)

Country Link
NZ (1) NZ591757A (en)

Similar Documents

Publication Publication Date Title
CY1122672T1 (en) ENHANCED NANOBODIESTM AGAINST TUMOR NECROSION FACTOR ALPHA
PH12019500694A1 (en) Factor viii compositions and methods of making and using the same
MX2009012650A (en) Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders.
TN2012000372A1 (en) Fibronectin based scaffold domain proteins that bind il-23
MX337040B (en) 4-1bb binding molecules.
MX2022013520A (en) Cxcr2 binding polypeptides.
MX2009010492A (en) Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells.
EP2470670A4 (en) Coagulation factor vii compositions and methods of making and using same
MX2010005783A (en) Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same.
MX2011013183A (en) Growth hormone polypeptides and methods of making and using same.
IN2012DN03368A (en)
MX369726B (en) Polypeptides having protease activity.
NZ724196A (en) Uti fusion proteins
EP1984013A4 (en) Modifications of cst-ii for increased protein expression
WO2012175745A9 (en) Cell secreted proteins for the treatment of myocardial infarction
NZ591757A (en) Modified variant bowman birk protease inhibitors
TN2013000171A1 (en) Cxcr2 binding polypeptides

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: DANISCO US INC., US

Free format text: OLD OWNER(S): DANISCO US INC., GENENCOR DIVISION

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 15 OCT 2015 BY HOULIHAN2

Effective date: 20130131

LAPS Patent lapsed